Host: Jerome Lisk, MD

Guest: Merle Diamond, MD

With migraine as a major global health problem that affects over 10% of the population, approximately 1 billion globally, and about 12% in the US, now more than ever it’s vital that healthcare professionals have a deep understanding of the role of the calcitonin gene-related peptide (CGRP) and its receptor in migraine pathophysiology1,2,3. That’s why Dr. Merle Lea Diamond joins Dr. Jerome Lisk to review that and more.

1. GBD 2017 Disease and Injury Incidence and Prevalence Collaborators. Lancet. 2018;392:1789-1858.
2. Lipton RB, et al. Neurology. 2007;68:343-349.
3. Lassen LH, et al. Cephalalgia. 2002;22:54-61.

USA-334-84583